NIH Hands Cancer Cure Tech to Startup, Sparking Treatment Race
Published Date: 5/6/2026
Notice
Summary
The National Cancer Institute plans to give OncoVanta Therapeutics an exclusive license to develop and sell special engineered cell therapies that target cancer. This means OncoVanta will have the sole right to use these patented inventions, which could speed up new cancer treatments. Anyone interested must send comments or license requests by May 21, 2026.
Free Policy Watch
New rules are filed every week. Most people never see them.
Pick a topic. PRIA watches every federal rule and tells you when one hits your household.
Pick a topic to get started
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Take the PRIA Score to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in